Biocon surges 14% after US FDA gives approval to biosimilar version of Herceptin News News / News 6 years ago 488 Views comments Mylan and Biocon said that USFDA approved Mylanâs Ogivri, a biosimilar to Swiss biotech giant Roche#39;s blockbuster cancer drug Herceptin, co-devel... Read more
News Buy BEML, HCL Tech, Titan, Engineers India; sell Ramco Cements: Mitessh Thakkar News / News - 6 years ago
News Clarify stand to scrap Rs 2,000 notes and introduce Rs 1,000 coins, says Opposition News / News - 6 years ago
Comments